Glaucoma Treatment MarketThe global glaucoma treatment market, valued at USD 5.7 billion in 2022, is projected to grow at a CAGR of 3.18% during the forecast period, reaching an estimated USD 8.0 ...

Approval was based on results from the Phase IIIb FLOW trial, which demonstrated a 24% relative risk reduction in kidney ...

New research published in Cureus has examined the reasons for non-attendance among a small sample of patients eligible for ...

USA News Group News Commentary – The United States is poised for a transformative leap in AI innovation as President Trump unveiled a private massive $500 billion investment ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) significantly reduce the risk for clinically meaningful chronic kidney disease (CKD) progression and major adverse cardiovascular events (MACE) in ...

States Say Medicaid Payments Pause as White House Defends Funding Freeze President Trump’s order freezing trillions of dollars in federal grants and loans seeks to eliminate all spending on ...